Feasibility of Patient-Centered Home Care (PCHC) to Reduce Disparities in High-Risk Black Men (BM) With Prostate Cancer (CaP)

Inclusion Criteria19

• GROUP 1 FOCUS GROUPS:
• Individuals identifying as Black and male who are familiar with the landscape of medical care and cancer
• GROUP 1 SURVEYS:
• Are 18 years of age or older
• Have histologic evidence of prostate adenocarcinoma
• Are requiring, have required, or will require prostate cancer treatment
• Have an understanding of the protocol and its requirements
• Are willing to fill in a questionnaire and participate in a focused interview
• Are able and willing to sign an informed consent
• GROUP 1 INTERVIEWS:
• Enrollment in the survey phase of the protocol
• GROUP 2:
• Are 18 years of age or older
• Are Black men or other discounted patients (older adults, individuals residing in rural or remote areas, and those facing transportation challenges)
• Have histologic evidence of prostate adenocarcinoma
• Are requiring active standard hormone-based therapies (degarelix or leuprolide), antibone resorptive agents (zoledronic acid or denosumab), oral anticancer treatments (abiraterone or second-generation androgen receptor blockers) or intravenous chemotherapy (docetaxel)
• Are receiving part of supportive care/symptom management and/or anti-cancer therapy in the home as part of Cancer Care Beyond Walls (CCBW)
• Have an understanding of the protocol and its requirements
• Are able and willing to sign informed consent